This study is looking at how well Pumitamig works compared to Pembrolizumab for treating advanced Non-Small Cell Lung Cancer. Both medicines are being tested as first treatments for patients with a specific type of this cancer. The goal is to see which treatment helps patients live longer without their cancer getting worse.
The trial's ID number is NCT07361510. It is a Phase 3 trial, meaning it is looking closely at how well the treatments work and how safe they are. It is FDA-regulated and aims to include about 750 participants.
Who can join
Adults aged 18 and older can join this study. It is open to both men and women who have not received treatment before for their cancer. Participants must have advanced Non-Small Cell Lung Cancer with a certain level of a protein called PD-L1. The trial team will confirm who is eligible.
Condition
Non-Small Cell Lung Cancer (NSCLC)
Age group
Adult, Older adult
Sex
All sexes
The study team makes the final call on eligibility.
What happens in the study
Participants will be put into two groups by chance. One group will receive Pumitamig, while the other group will get Pembrolizumab. Both groups will take their assigned medicine on specific days. The study will look at how long patients live without their cancer getting worse and overall survival.
Where
This trial is enrolling at 40 locations. Recruiting sites are listed first.
Advanced Research
Coral Springs, Florida
Recruiting
BRP- Hialeah Hospital
Hialeah, Florida
Recruiting
Clermont Oncology Center
Clermont, Florida
Recruiting
HSHS St. Vincent Hospital Regional Cancer Center
Green Bay, Wisconsin
Recruiting
Kelsey-Seybold Clinic Main Campus
Houston, Texas
Recruiting
Missouri Cancer Associates
Columbia, Missouri
Recruiting
Mohtaseb Cancer Center & Blood Disorders
Bullhead City, Arizona
Recruiting
Northwest Cancer Centers, P.C.
Dyer, Indiana
Recruiting
Study contact
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
Chief of Thoracic Surgery and Director of the Lung Cancer Program at West Virginia University Cancer Institute. Treats lung cancer and esophageal cancer.
Treats pancreatic cancer, lung cancer and colorectal cancer. The main cancer doctor for adults. Manages your treatment and your care team. Recognized at state, national or international level.
Led the National Lung Screening Trial. Treats lung cancer. Other doctors who help with cancer care, like gastroenterologists, dermatologists, and endocrinologists. Recognized at state, national or international level.